SCHEMBL6924615

SCHEMBL6924615

CC(C)Oc1ccccc1C1(O)CCN(Cc2ccccc2)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 3/20 0.57
POLB P06746 1/20 0.55
CCR3 P51677 1/20 0.51
CHRM4 P08173 1/20 0.50
CCR8 P51685 1/20 0.49
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47
OPRK1 P41145 1/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP2D6 P10635 3/20 0.47
TP53 P04637 2/20 0.47
CYP3A4 P08684 2/20 0.47
GMNN O75496 1/20 0.47
LMNA P02545 1/20 0.47
DRD2 P14416 1/20 0.47
HPGD P15428 1/20 0.47
DRD4 P21917 1/20 0.47
DRD3 P35462 1/20 0.47
PMP22 Q01453 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2970071 0.85 CHRM4 (0.64) OPRL1POLBCCR3CHRM4CCR8
SCHEMBL31028218 0.85 CHRM4 (0.64) OPRL1POLBCCR3CHRM4CCR8
SCHEMBL19556804 0.82 OPRL1 (0.49) OPRL1POLBCCR3CCR8ALDH1A1
SCHEMBL1513216 0.82 OPRL1 (0.60) OPRL1POLBCCR3CHRM4CCR8
SCHEMBL7490166 0.82 OPRL1 (0.60) OPRL1POLBCCR3CHRM4CCR8
SCHEMBL6924622 0.81 OPRL1 (0.56) OPRL1POLBCCR3CHRM4CCR8
SCHEMBL2326503 0.79 OPRL1 (0.60) OPRL1POLBCCR3OPRM1OPRD1
SCHEMBL6911078 0.79 OPRL1 (0.71) OPRL1POLBCCR3ALDH1A1CYP2D6
SCHEMBL18304932 0.79 OPRL1 (0.44) OPRL1POLBCCR3CCR8ALDH1A1
SCHEMBL2883677 0.78 OPRL1 (0.66) OPRL1POLBCCR3OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030120070-A1 Serotonin 5-HT1A and dopamin D2 receptor ligands H. LUNDBECK A/S (DE) 2003-06-26 US disclosed
US-6514993-B1 Useful in the treatment of certain psychic and neurologic disorders H. LUNDBECK A/S (DK) 2003-02-04 US disclosed
EP-0770066-B1 SEROTONIN 5-HT 1A AND DOPAMIN D2 RECEPTOR LIGANDS LUNDBECK & CO AS H (DK) 2000-05-17 EP disclosed
EP-0770066-A1 SEROTONIN 5-HT 1A AND DOPAMIN D2 RECEPTOR LIGANDS H. LUNDBECK A/S (DK) 1997-05-02 EP disclosed
WO-1995033729-A1 SEROTONIN 5-HT1A AND DOPAMIN D2 RECEPTOR LIGANDS H. LUNDBECK A/S (DK) 1995-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030120070-A1 Serotonin 5-HT1A and dopamin D2 receptor ligands HTR5A, HTR2C, HTR1D OPRL1 37/4885POLB 3843/4885CCR3 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.